WEISS MICHAEL S 4
4 · TG THERAPEUTICS, INC. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
WEISS MICHAEL S
DirectorCEO
Transactions
- Award
Common Stock
2024-01-06+1,001,908→ 13,074,929 total
Footnotes (2)
- [F1]Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date.
- [F2]Includes shares of restricted Common Stock, which vest over various time periods.